These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 2125253)
1. Correlation between T cells and experimental crescentic glomerulonephritis. Zou WZ; Zhou KX Chin Med J (Engl); 1990 Oct; 103(10):805-10. PubMed ID: 2125253 [TBL] [Abstract][Full Text] [Related]
2. [The roles of T cells in experimental crescentic glomerulonephritis]. Zhou KX; Zou WZ Zhonghua Bing Li Xue Za Zhi; 1992 Apr; 21(2):100-2. PubMed ID: 1499070 [TBL] [Abstract][Full Text] [Related]
3. Apoptosis in progressive crescentic glomerulonephritis. Shimizu A; Masuda Y; Kitamura H; Ishizaki M; Sugisaki Y; Yamanaka N Lab Invest; 1996 May; 74(5):941-51. PubMed ID: 8642789 [TBL] [Abstract][Full Text] [Related]
4. Immune modulation with interleukin-4 and interleukin-10 prevents crescent formation and glomerular injury in experimental glomerulonephritis. Tipping PG; Kitching AR; Huang XR; Mutch DA; Holdsworth SR Eur J Immunol; 1997 Feb; 27(2):530-7. PubMed ID: 9045927 [TBL] [Abstract][Full Text] [Related]
5. Important role for macrophages in induction of crescentic anti-GBM glomerulonephritis in WKY rats. Isome M; Fujinaka H; Adhikary LP; Kovalenko P; El-Shemi AG; Yoshida Y; Yaoita E; Takeishi T; Takeya M; Naito M; Suzuki H; Yamamoto T Nephrol Dial Transplant; 2004 Dec; 19(12):2997-3004. PubMed ID: 15574997 [TBL] [Abstract][Full Text] [Related]
7. The evolution of crescentic nephritis and alveolar haemorrhage following induction of autoimmunity to glomerular basement membrane in an experimental model of Goodpasture's disease. Reynolds J; Moss J; Duda MA; Smith J; Karkar AM; Macherla V; Shore I; Evans DJ; Woodrow DF; Pusey CD J Pathol; 2003 May; 200(1):118-29. PubMed ID: 12692850 [TBL] [Abstract][Full Text] [Related]
8. Resistance of CD28-deficient mice to autologous phase of anti-glomerular basement membrane glomerulonephritis. Nitta K; Horita S; Ogawa S; Matsumoto M; Hara Y; Okano K; Hayashi T; Abe R; Nihei H Clin Exp Nephrol; 2003 Jun; 7(2):104-12. PubMed ID: 14586728 [TBL] [Abstract][Full Text] [Related]
9. Inducible co-stimulatory molecule ligand is protective during the induction and effector phases of crescentic glomerulonephritis. Odobasic D; Kitching AR; Semple TJ; Holdsworth SR J Am Soc Nephrol; 2006 Apr; 17(4):1044-53. PubMed ID: 16540559 [TBL] [Abstract][Full Text] [Related]
10. T cells in crescentic glomerulonephritis. Tipping PG; Holdsworth SR J Am Soc Nephrol; 2006 May; 17(5):1253-63. PubMed ID: 16624930 [TBL] [Abstract][Full Text] [Related]
11. Prevention of crescentic glomerulonephritis induced by anti-glomerular membrane antibody in tumor necrosis factor-deficient mice. Le Hir M; Haas C; Marino M; Ryffel B Lab Invest; 1998 Dec; 78(12):1625-31. PubMed ID: 9881962 [TBL] [Abstract][Full Text] [Related]
12. Crescentic glomerulonephritis in interferon-gamma receptor deficient mice. Haas C; Ryffel B; Le Hir M J Inflamm; 1995-1996; 47(4):206-13. PubMed ID: 9144077 [TBL] [Abstract][Full Text] [Related]
13. A pathogenetic role for mast cells in experimental crescentic glomerulonephritis. Timoshanko JR; Kitching AR; Semple TJ; Tipping PG; Holdsworth SR J Am Soc Nephrol; 2006 Jan; 17(1):150-9. PubMed ID: 16319187 [TBL] [Abstract][Full Text] [Related]
14. Sequential studies of glomerular crescent formation in rats with antiglomerular basement membrane-induced glomerulonephritis and the role of coagulation factors. Silva FG; Hoyer JR; Pirani CL Lab Invest; 1984 Oct; 51(4):404-15. PubMed ID: 6434880 [TBL] [Abstract][Full Text] [Related]